当前位置:首页 - 行情中心 - 普洛药业(000739) - 财务分析

普洛药业

(000739)

  

流通市值:160.69亿  总市值:160.75亿
流通股本:11.78亿   总股本:11.79亿

普洛药业(000739)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润2.44亿元,每股收益0.21元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益647487.43万元,未分配利润476375.13万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产1347635.07万元,负债700147.63万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入3,198,046,619.8611,474,162,365.598,500,085,529.085,954,455,753.01
营业总成本2,862,663,780.7810,231,011,582.857,444,588,905.925,192,091,158.3
营业利润300,298,363.681,220,141,953.11,013,524,987.41708,930,411.59
利润总额299,489,946.111,204,644,060.731,004,694,696.3707,357,036.37
净利润243,714,001.081,055,306,898.23851,314,493.27601,044,120.54
其他综合收益743,150.252,798,837.27-3,095,693.43-3,090,949.21
综合收益总额244,457,151.331,058,105,735.5848,218,799.84597,953,171.33
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计9,054,659,617.928,368,160,381.148,264,143,161.78,391,675,844.48
非流动资产合计4,421,691,043.194,399,503,691.24,355,542,490.954,283,099,581.85
资产总计13,476,350,661.1112,767,664,072.3412,619,685,652.6512,674,775,426.33
流动负债合计6,774,846,214.556,307,727,821.646,276,641,195.786,572,961,655.63
非流动负债合计226,630,098.99229,519,054.46322,514,196.29331,924,138.63
负债合计7,001,476,313.546,537,246,876.16,599,155,392.076,904,885,794.26
归属于母公司股东权益合计6,467,188,315.676,222,728,875.436,012,837,687.85,762,563,679.16
股东权益合计6,474,874,347.576,230,417,196.246,020,530,260.585,769,889,632.07
负债和股东权益合计13,476,350,661.1112,767,664,072.3412,619,685,652.6512,674,775,426.33
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计2,462,380,847.099,675,069,875.896,611,497,273.964,343,031,678.23
经营活动现金流出小计2,182,255,373.228,643,706,801.815,762,956,833.13,600,658,437.55
经营活动产生的现金流量净额280,125,473.871,031,363,074.08848,540,440.86742,373,240.68
投资活动现金流入小计7,600,000126,616,367.02101,622,427.2563,431,472.96
投资活动现金流出小计195,742,141.05803,414,311.69562,424,138.58292,742,769.44
投资活动产生的现金流量净额-188,142,141.05-676,797,944.67-460,801,711.33-229,311,296.48
筹资活动现金流入小计260,000,0001,061,555,916.671,025,375,000695,000,000
筹资活动现金流出小计222,479,954.61,363,039,752.351,334,712,260.68933,436,043.31
筹资活动产生的现金流量净额37,520,045.4-301,483,835.68-309,337,260.68-238,436,043.31
汇率变动对现金及现金等价物的影响7,083,124.5127,492,395.9335,150,950.5237,622,206.77
现金及现金等价物净增加额136,586,502.7380,573,689.66113,552,419.37312,248,107.66
期末现金及现金等价物余额2,599,072,264.472,462,485,761.742,495,464,491.452,694,160,179.74
最新报告期:2024-04-23
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
中泰证券祝嘉琦0.991.161.372024-04-23
招商证券许菲菲0.991.141.332024-04-19
广发证券方程嫣,罗佳荣1.001.191.462024-03-22
国信证券张佳博,彭思宇1.041.191.352024-03-17
兴业证券孙媛媛,黄翰漾1.051.281.552024-03-12
TOP↑